Skip to content

Clinical trials

Brain Neoplasms trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Not applicable Country / region: United States Clear all

219 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20032
20044
20052
20064
20075
20084
20097
20106
20117
201211
201312
20147
20159
20165
201716
201815
201913
202010
202110
202212
202314
202410
202513
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed83
Recruiting54
Terminated34
Active, not recruiting22
Withdrawn14
Not yet recruiting4
Unknown status4
Suspended2
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center14
M.D. Anderson Cancer Center11
Mayo Clinic11
Massachusetts General Hospital10
Virginia Commonwealth University9
Duke University8
Jonsson Comprehensive Cancer Center7
Brigham and Women's Hospital5
Case Comprehensive Cancer Center5
Emory University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms219
Glioblastoma33
Glioma31
Lung Neoplasms12
Astrocytoma10
Breast Neoplasms10
Head and Neck Neoplasms10
Neoplasm Metastasis10
Oligodendroglioma10
Meningioma9

Trials

Showing 1 to 25 of 219. Each trial links to its page on Pharma Observatory.

119 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.